Elsevier

Legal Medicine

Volume 16, Issue 2, March 2014, Pages 89-91
Legal Medicine

Case report
Fatal water intoxication during olanzapine treatment: A case report

https://doi.org/10.1016/j.legalmed.2013.12.003Get rights and content

Abstract

A man in his twenties was diagnosed with schizophrenia in his late teens. The night before his death, his family reported he drank a large amount of water, vomited, collapsed, and snored loudly while sleeping, but they did not view the event seriously as he did it routinely. The following morning, he was found dead. Autopsy revealed hyponatremia by water intoxication as the cause of death. Water intoxication has various causes. In this case, 610 ng/mL olanzapine was detected in serum samples. Although this concentration is not as high as the fatal concentrations reported in past studies, it might have caused some adverse effects. Furthermore, the observation that excessive drinking behavior started after the dose of olanzapine was increased suggests a possibility that olanzapine aggravated water intoxication.

Introduction

Olanzapine is one of the most common antipsychotic drugs used for first-line treatment of schizophrenia in Japan. It is widely used worldwide as it can also be used to treat bipolar depression. Olanzapine has various affinities for multiple receptors, including those for dopamine D2, serotonin 5-hydroxytryptamine (HT)2A, 5-HT2C, 5-HT6, adrenaline alpha-1, histamine H1, and muscarine M1–M5 [1]. Therefore, olanzapine is associated with various clinical and toxic manifestations [2], [3], [4], [5], [6]. In particular, dry mouth caused by metabolic disorder, a known adverse effect of olanzapine, occurs significantly more frequently in patients treated with olanzapine than in those treated with other drugs. In this study, we report a case of death from water intoxication while receiving olanzapine treatment. Although various factors are known to cause water intoxication, an adverse effect of olanzapine in the present case might have aggravated water intoxication.

Section snippets

Case report

A man in his twenties who was diagnosed with schizophrenia at in his late teens had over the few months preceding his death drunk such large amounts of water that his abdomen was expanded and he had been vomiting and collapsing. The night before his death, his family reported he drank a large amount of water, vomited, collapsed, and snored loudly while sleeping, but they did not view the event seriously as he did it routinely. The following morning, he was found dead. He had no history of

Cadaveric study

To compare against the findings of the present case, postmortem changes in electrolyte concentrations were examined in the serum and vitreous humor obtained from 18 cadavers (15 males, 3 females; aged 25 ̃ 86 years, mean age of 60.88 years at time of death) at 1–10 days postmortem (Table 1). Cadavers with causes of death that may have affected body fluid composition were excluded.

Results

As shown in Table 2, the mean (±standard deviation) sodium concentration for the 18 cadavers was 108.4 ± 9.58 mEq/L in the serum, 129.44 ± 8.84 mEq/L in the right vitreous humor, and 132.76 ± 10.28 mEq/L in left vitreous humor, concentrations that were higher than in the present case.

Discussion

Although there is currently no established diagnostic standard for water intoxication, a diagnosis is based on the observation of behavior such as polyposia, blood test results such as hyponatremia, and previous clinical history such as epileptic stroke and disturbance of consciousness [7]. In the present case, a large amount of water was consumed before death, autopsy revealed edema in the brain and lung, and the vitreous sodium concentration, which has been shown to be relatively resistant to

Conclusion

The cause of death in this case was judged to be hyponatremia by water intoxication based on the results of the autopsy, biochemical examination, and drug test. Moreover, it is likely that an adverse effect of olanzapine in the present case might have aggravated water intoxication.

References (21)

There are more references available in the full text version of this article.

Cited by (13)

  • Relationship between polydipsia and antipsychotics: A systematic review of clinical studies and case reports

    2020, Progress in Neuro-Psychopharmacology and Biological Psychiatry
    Citation Excerpt :

    Fig. 1 shows the flow of the systematic literature search. Among 708 records, we identified and included 1 RCT (Goldman and Hussain, 2004), 4 single-arm trials (Canuso and Goldman, 1999; Kawai et al., 2002; Millson et al., 1996; Millson and Delva, 1999), 1 cross-sectional study (Serrano et al., 2014), 3 case series, not providing the detailed information of each case but reporting a summary of cases (Henderson and Goff, 1994; Peh et al., 1990; Spears et al., 1996), and 52 case reports (Adetoki et al., 2013; Afzal et al., 2007; Aguiar et al., 2015; Akkaya et al., 2006; Bersani et al., 2007; Caykoylu et al., 2009; Cecconi et al., 2016; Chiang et al., 2013; Costanzo et al., 2004; de Leon, 2003; Diniz et al., 2010; Dogangun et al., 2006; Ellinas et al., 1993; Faruqi and Mukkera, 2012; Fuller et al., 1996; Funayama et al., 2011; Girard-Martel and Gagnon, 2018; Gleadhill et al., 1982; Glusac et al., 1990; Godleski et al., 1989; Graham and Jawed, 1998; Gumber and Shah, 2014; Kar et al., 2002; Katsarou and Singh, 2010; Kern et al., 1997; Kruse et al., 2001; Landry, 1995; Li et al., 2012; Littrell et al., 1997; Looi et al., 1995; Margetic et al., 2006; Mauri et al., 2002; Mendelson and Deza, 1976; Nagasawa et al., 2014; Narendra et al., 2014; Nishikawa et al., 1991; Okazaki et al., 2007; Perestleo and Teixeira, 2016; Phull and Davies, 2011; Rao et al., 2011; Samaranayake et al., 2013; Secombe and Milne, 2016; Shen and Sata, 1983; Shenoi and Stockwell, 2015; Suzuki et al., 2008; Tanimoto et al., 1997; Tenyi and Voros, 2006; Wicki et al., 1998; Williamson et al., 2015; Zaidi, 2005; Zilles et al., 2010; Zink et al., 2004). Table 1 summarizes the findings of the identified 1 double-blind RCT, 4 single-arm trials, 1 cross-sectional study, and 3 case series on polydipsia and antipsychotics.

  • Bionanocomposite systems based on montmorillonite and biopolymers for the controlled release of olanzapine

    2017, Materials Science and Engineering C
    Citation Excerpt :

    OLZ has high permeability in biological membranes but low solubility in aqueous media, thus belonging to Class II according to the Biopharmaceutical Classification System [5,6]. Low water solubility increases the difficulty of dissolution and absorption of drug substances in the body, which affects the treatment of diseases [7] and has even been shown to contribute to fatal intoxication in the body [8]. Generally, oral administration affects the amount of available drug that accesses the systemic circulation after passing through the hepatic system (first pass effect).

  • An autopsy case of fatal water intoxication with postmortem computed tomography findings of diluted intestinal content and hemodilution

    2016, Journal of Forensic Radiology and Imaging
    Citation Excerpt :

    In addition, no specific pathognomonic tissue changes establish death from water intoxication [8], which makes a postmortem diagnosis of water intoxication difficult. The vitreous humor is presumed to be more available for postmortem biochemistry analysis, because there are fewer postmortem influences [10,11]; however, the vitreous humor is not always sampled in daily forensic practice. Recently, the role of postmortem computed tomography (PMCT) as an adjunct to conventional autopsy has been well documented [12], although only clinical cases and animal models have been reported in terms of water intoxication [13,14].

  • Antipsychotic Drugs

    2015, Side Effects of Drugs Annual
    Citation Excerpt :

    A study found that patients with SULT4A1-1-positive status experienced significantly less weight gain [186c]. A case of a male in his twenties on olanzapine who died of hyponatremia associated with water intoxication and high serum levels of olanzapine (610 ng/mL) is reported [187]. Two cases of postinjection delirium/sedation syndrome are reported [188A], including a 46-year-old male 4 hours post injection [189A].

View all citing articles on Scopus
View full text